Print Page | Contact Us | Sign In | Join
Industry News: News

Allergan Receives FDA Approval for Juvéderm Voluma XC for Mid-face Injection via Cannula

Wednesday, September 11, 2019   (0 Comments)
Share |

Allergan plc has announced it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC, a hyaluronic acid gel dermal filler, with a TSK Steriglide cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21. A cannula is a thin, flexible tube with a rounded tip that can serve as an effective delivery system. Use of a cannula allows for injection of Juvéderm Voluma XC in the cheek area. The TSK Steriglide has a unique design compared to other cannulas available on the market and features a patented tip design with a near-tip delivery port for precise product placement.

Read more at PR Newswire >>

Contact Us

224 N Desplaines, Ste. 300
 Chicago, IL 60661

Phone: 312-981-0993

Fax: 888-827-8860


AmSpa provides legal, compliance, and business resources for medical spas and medical aesthetic practices.

Follow Us: